Position in ERAS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$32,316,111
+$3,412,339 QoQ
Shares Held
1,763,980
-1.3% QoQ
Ownership
0.504%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 257 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 80%
Shared 8%
None 11%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ERAS ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ERAS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,316,111 | 1,763,980 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $28,903,772 | 1,786,389 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,605,546 | 1,775,685 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,990,817 | 1,371,935 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,150,646 | 1,693,423 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,518,234 | 1,838,128 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,301,082 | 2,111,986 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,298,655 | 1,208,299 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,180,136 | 500,058 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $659,737 | 320,261 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $801,280 | 376,188 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $373,442 | 189,565 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $119,706 | 43,372 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $241,931 | 80,376 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $265,444 | 61,588 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||